Literature DB >> 3521682

Glycosylation accelerates albumin degradation in normal and diabetic dogs.

M A Morris, L Preddy.   

Abstract

Nonenzymatic glycosylation of albumin was associated with an increased catabolic rate and decreased protein half-life in both normal and diabetic animals. The fractional catabolic rate of glycosylated albumin was increased significantly over albumin, from 0.100 +/- 0.004/day to 0.131 +/- 0.007/day in normal animals and from 0.104 +/- 0.004/day to 0.138 +/- 0.007/day when these animals were made diabetic with alloxan. The half-lives of Alb and GlyAlb in normal dogs were 6.81 +/- 0.12 days and 4.97 +/- 0.21 days, respectively. In diabetic animals, the half-lives of Alb and GlyAlb were 7.48 +/- 0.21 and 5.21 +/- 0.24 days, respectively. The increased catabolism of GlyAlb may reflect chronic increased extravasation of glycosylated plasma proteins, which are known to be increased in diabetes, into the microvascular wall.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521682     DOI: 10.1016/0885-4505(86)90082-4

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  5 in total

1.  L-Arginine inhibits in vitro nonenzymatic glycation and advanced glycosylated end product formation of human serum albumin.

Authors:  D A Servetnick; D Bryant; K J Wells-Knecht; P L Wiesenfeld
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

2.  Suggested mechanism for the selective excretion of glucosylated albumin. The effects of diabetes mellitus and aging on this process and the origins of diabetic microalbuminuria.

Authors:  A Kowluru; R Kowluru; M W Bitensky; E J Corwin; S S Solomon; J D Johnson
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

3.  Association between serum albumin and glycated hemoglobin in Asian Indian subjects.

Authors:  Shalbha Tiwari; Manish Bothale; Imtiaz Hasan; Mahesh J Kulkarni; Mehmood G Sayyad; Rita Basu; Ananda Basu; Ambika Gopalakrishnan Unnikrishnan
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

Review 4.  Albumin-based drug delivery: harnessing nature to cure disease.

Authors:  Maja Thim Larsen; Matthias Kuhlmann; Michael Lykke Hvam; Kenneth A Howard
Journal:  Mol Cell Ther       Date:  2016-02-27

5.  A Preliminary Study of Modulen IBD Liquid Diet in Hospitalized Dogs with Protein-Losing Enteropathy.

Authors:  Aarti Kathrani; Gina Parkes
Journal:  Animals (Basel)       Date:  2022-06-20       Impact factor: 3.231

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.